They have right to live with dignity: Kerala High Court grants parole to man sentenced for life to undergo IVF treatment

-

A man sentenced to life imprisonment in Kerala has been granted parole by the High Court for In Vitro Fertilization (IVF) treatment.

The Kerala High Court observed that the convict has the right to live a dignified life.

The court has directed the prison DGP to grant parole of at least 15 days to the convict serving his sentence in Viyyur.

The Jail DGP has also been directed to take action within two weeks.

“They have the right to live with dignity like any citizen. The petitioner submitted the letter from the hospital authorities, as part of her request to grant parole to her husband. Earlier, she approached the concerned authorities to grant parole for three months, but to no avail. Then they approached the High Court. At the same time, the government lawyer was of the view that parole cannot be granted,” Justice PV Kunhikrishnan said.

“It is submitted that for effective treatment, the petitioner’s husband’s presence along with the petitioner for three months is highly necessary,” the High Court said.

The court recalled that purity of purpose of demand is important and criminals cannot use such demand to get out of jail. At the same time, the High Court also pointed out that each case will be considered based on purity of intention.

The Kerala High Court intervened in a petition filed by the wife of the convict. The court issued the order asking how it can turn a blind eye to reasonable pleas on account of technicality. Punishment for crimes is also to repent. Those who come out after the punishment should be seen as a part of the society. A person who has served a prison sentence and is released should not be treated with discrimination.

With inputs from ANI



from Firstpost India Latest News https://ift.tt/ojuDaNv
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more